Press Releases Virios Therapeutics, Inc.

Equities

VIRI

US92829J1043

Delayed Nasdaq Other stock markets 02:47:18 2024-04-29 pm EDT			5-day change	1st Jan Change
0.4624 ^USD	-1.51%		+8.64%	-19.57%

Feb. 29	Virios Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
Jan. 22	Virios Therapeutics Announces Plans to Advance Development of Imc-2 as Treatment for Symptoms Associated with Long-Covid	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID	Mar. 26	AQ
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 01	AQ
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones	Feb. 29	AQ
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results	Feb. 29	AQ
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones	Feb. 28	AQ
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID	Jan. 22	AQ
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID	Jan. 02	AQ
Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 13	AQ
Virios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023	Nov. 06	AQ
Thinking about buying stock in Aware, Virios Therapeutics, Bit Brother, Confluent, or Blue Star Foods?	Nov. 03	PR
Virios Therapeutics to Present at the ThinkEquity Conference on Thursday, October 19, 2023	23-10-12	AQ
Virios Therapeutics Announces Termination of At-The-Market Sales Agreement	23-09-18	AQ
Virios Therapeutics CEO Greg Duncan to Present at the SHARE Series Investor Event on Monday, September 18, 2023	23-09-13	AQ
Virios Therapeutics CEO Greg Duncan to Present at the SHARE™️ Series Investor Event on Monday, September 18, 2023	23-09-12	AQ
Virios Therapeutics Announces Halt to At-The-Market Offering Sales	23-08-14	AQ
Virios Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-10	AQ
Virios Therapeutics Announces Plans to Advance Lead Candidate IMC-1 to Phase 3 Development as a New Treatment Option for Fibromyalgia	23-08-09	AQ
Virios Therapeutics to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023	23-08-03	AQ
Virios Therapeutics Announces Positive Data Demonstrating Improvement in Multiple Long-COVID Symptoms Following Treatment with a Combination of Valacyclovir and Celecoxib in an Exploratory, Open-Label, Proof of Concept Study	23-07-17	AQ
VIRIOS THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-06-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Virios Therapeutics, Inc.

Equities

VIRI

US92829J1043

Press Releases

Filters